Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Ploner Ferdinand |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2015
Originalarbeit (Zeitschrift)
** Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Knauer, M; Moik, M; Jakesz, R; Seifert, M; Taucher, S; Bjelic-Radisic, V; Balic, M; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Selim, U; Fitzal, F; Hochreiner, G; Wette, V; Sevelda, P; Ploner, F; Bartsch, R; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol. 2015; 26(2):313-320
Doi: 10.1093/annonc/mdu544
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Gary, T; Leithner, A; Pichler, M
Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients.
Clin Chem Lab Med. 2015; 53(3):493-497
Doi: 10.1515/cclm-2014-0486
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Issels, RD; Lindner, LH; Ghadjar, P; Reichardt, P; Hohenberger, P; Verweij, J; Abdel-Rahman, S; Daugaard, S; Salat, C; Vujaskovic, Z; Wessalowski, R; Duerr, HR; Ploner, F; Mella, O; Schmidt, M; Mansmann, U; Jauch, KW; Belka, C; Hiddemann, W; Gronchi, A
Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study
EUR J CANCER. . 2015; 51: S716-S716.-European Cancer Congress; 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0959-8049(15)30071-X
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Mir, O; Brodowicz, T; Wallet, J; Italiano, A; Le Cesne, A; Blay, JY; Ryckewaert, T; Bertucci, F; Piperno-Neumann, S; Ploner, F; Toulmonde, M; Domont, J; Saada, E; Delcambre, C; Isambert, N; Delaine, SC; Taieb, S; Lindner, E; Lieg-Atzwanger, B; Penel, N
Activity of regorafenib (RE) in leiomyosarcomas (LMS) and other types of soft-tissue sarcomas (OTS): Results of a doubleblind, randomized placebo (PL) controlled phase II trial
J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
Web of Science
** Ploner, F; Plank, J; Humer-Fuchs, U; Lax, S; Noggler, P; Rosanelli, G; Stepan, V
Hypoglycaemia in a Patient with Glucagonoma-Coincidence of a Glucagonoma and Insulinoma in a Patient with Multiple Endocrine Neoplasia Type I
NEUROENDOCRINOLOGY. . 2015; 102(1-2):153-153.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN.
[Oral Communication]
Web of Science
2014
Originalarbeit (Zeitschrift)
** Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T
Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853
Doi: 10.1097/CAD.0000000000000108
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Stotz, M; Samonigg, H; Ploner, F; Stojakovic, T; Leithner, A; Pichler, M
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
PLoS One. 2014; 9(9):e107297-e107297
Doi: 10.1371/journal.pone.0107297
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Eberhard, K; Leithner, A; Gerger, A
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
J Surg Oncol. 2014; 109(2):139-144
Doi: 10.1002/jso.23458
Web of Science
PubMed
FullText
FullText_MUG
2013
Originalarbeit (Zeitschrift)
** Andritsch, E; Stöger, H; Bauernhofer, T; Andritsch, H; Kasparek, AK; Schaberl-Moser, R; Ploner, F; Samonigg, H
The ethics of space, design and color in an oncology ward.
Palliat Support Care. 2013; 11(3):215-221
Doi: 10.1017/S1478951512000077
Web of Science
PubMed
FullText
FullText_MUG
** Bareck, E; Ba-Ssalamah, A; Brodowicz, T; Eisterer, W; Häfner, M; Högenauer, C; Kastner, U; Kühr, T; Längle, F; Liegl-Atzwanger, B; Schoppmann, SF; Widmann, G; Wrba, F; Zacherl, J; Ploner, F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine
Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.
Wien Med Wochenschr. 2013; 163(5-6):137-152
Doi: 10.1007/s10354-013-0187-3
PubMed
FullText
FullText_MUG
** Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414
Doi: 10.1038/bjc.2013.114
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ploner, F; Lamm, W; Schur, S; Eisterer, W; Kühr, T; Lindorfer, A; Tinchon, C; Köstler, WJ; Szkandera, J; Brodowicz, T
The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS).
J Cancer Res Clin Oncol. 2013; 139(8):1337-1342
Doi: 10.1007/s00432-013-1447-8
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Br J Cancer. 2013; 109(9):2316-2322
Doi: 10.1038/bjc.2013.595
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Originalarbeit (Zeitschrift)
** Brodowicz, T; Amann, G; Leithner, A; Sztankay, A; Kainberger, F; Eisterer, W; Liegl-Atzwanger, B; Rachbauer, F; Rath, T; Bergmann, M; Funovics, PT; Ploner, F; Windhager, R
Consensus diagnosis and therapy of soft tissue sarcoma.
Wien Klin Wochenschr. 2012; 124(3-4):85-99
Doi: 10.1007/s00508-011-0079-8
Web of Science
PubMed
FullText
FullText_MUG
2010
Originalarbeit (Zeitschrift)
** Issels, RD; Lindner, LH; Verweij, J; Wust, P; Reichardt, P; Schem, BC; Abdel-Rahman, S; Daugaard, S; Salat, C; Wendtner, CM; Vujaskovic, Z; Wessalowski, R; Jauch, KW; Dürr, HR; Ploner, F; Baur-Melnyk, A; Mansmann, U; Hiddemann, W; Blay, JY; Hohenberger, P; for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); the European Society for Hyperthermic Oncology (ESHO)
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Lancet Oncol. 2010; 11(6): 561-570.
Doi: 10.1016/S1470-2045(10)70071-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pircher, A; Ploner, F; Popper, H; Hilbe, W
Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients.
Lung Cancer. 2010; 69(3): 265-271.
Doi: 10.1016/j.lungcan.2010.01.017
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Gallè, G; Samonigg, H; Hofmann, G
Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies.
Onkologie. 2010; 33(8-9):452-454
Doi: 10.1159/000317269
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2009
Originalarbeit (Zeitschrift)
** Calabrò, A; Beissbarth, T; Kuner, R; Stojanov, M; Benner, A; Asslaber, M; Ploner, F; Zatloukal, K; Samonigg, H; Poustka, A; Sültmann, H
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
Breast Cancer Res Treat. 2009; 116(1):69-77
Doi: 10.1007/s10549-008-0105-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691
Doi: 10.1056/NEJMoa0806285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Hofmann, G; Ploner, F; Liegl-Atzwanger, B; Langsenlehner, T
Current nonsurgical treatment options and concepts for soft tissue sarcoma in adults
EUR SURG. 2009; 41(4): 170-175.
Doi: 10.1007/s10353-009-0480-y
Web of Science
FullText
FullText_MUG
** Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Wohlkoenig, C; Bálint, Z; Polachova, J; Olschewski, A; Samonigg, H; Popper, HH; Olschewski, H
Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
Lung Cancer. 2009; 65(1):98-104
Doi: 10.1016/j.lungcan.2008.10.015
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Ploner, F; Eisterer, W
Treatment of extensive disease
Wien Med Wochenschr. 2009; 159(15-16): 403-407.
Doi: 10.1007/s10354-009-0690-8
PubMed
FullText
FullText_MUG
** Ploner, F; Zacherl, J; Wrba, F; Langle, F; Bareck, E; Eisterer, W; Kuhr, T; Schima, W; Hafner, M; Brodowicz, T
Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria.
WIEN KLIN WOCHENSCHR. 2009; 121(23-24): 780-790.
Doi: 10.1007/s00508-009-1278-4
Web of Science
PubMed
FullText
FullText_MUG
** Ploner, F; Zacherl, J; Wrba, F; Längle, F; Bareck, E; Eisterer, W; Kühr, T; Schima, W; Häfner, M; Brodowicz, T; für das österreichische GIST-Panel
Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria
Wien Med Wochenschr. 2009; 159(15-16): 370-382.
Doi: 10.1007/s10354-009-0685-5
PubMed
FullText
FullText_MUG
2008
Originalarbeit (Zeitschrift)
** Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kässmann, H; Piswanger-Sölkner, JC; Seifert, M; Ploner, F; Menzel, C; Dubsky, P; Fitzal, F; Bjelic-Radisic, V; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Wohlmuth, P; Mittlböck, M; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Lancet Oncol. 2008; 9(9):840-849
Doi: 10.1016/S1470-2045(08)70204-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Leyvraz, S; Pampallona, S; Martinelli, G; Ploner, F; Perey, L; Aversa, S; Peters, S; Brunsvig, P; Montes, A; Lange, A; Yilmaz, U; Rosti, G; Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation
A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
J Natl Cancer Inst. 2008; 100(8): 533-541.
Doi: 10.1093/jnci/djn088
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mlineritsch, B; Tausch, C; Singer, C; Luschin-Ebengreuth, G; Jakesz, R; Ploner, F; Stierer, M; Melbinger, E; Menzel, C; Urbania, A; Fridrik, M; Steger, G; Wohlmuth, P; Gnant, M; Greil, R; on behalf of the Austrian Breast, Colorectal Cancer Study Group (ABCSG)
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).
Breast Cancer Res Treat. 2008; 112(1): 203-213.
Doi: 10.1007/s10549-007-9843-x
Web of Science
PubMed
FullText
FullText_MUG
** Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774.
Doi: 10.1158/1078-0432.CCR-07-4122
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Übersichtsarbeit
** Hilbe, W; Aigner, K; Dittrich, C; Eckmayr, J; Fiegl, M; Flicker, M; Forstner, B; Greil, R; Jamnig, H; Krajnik, G; Lang, A; Mohn-Staudner, A; Schinko, H; Studnicka, M; Pirker, R; Ploner, F; Rothmund, J; Schiller, L; Zabernigg, A; Zöchbauer-Müller, S
Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms
WIEN KLIN WOCHENSCHR. 2007; 119(7-8): 259-266.
Doi: 10.1007/s00508-007-0792-5
Web of Science
PubMed
FullText
FullText_MUG
** Ploner, F
NSCLC: update on second line therapy following ASCO 2007
Wien Med Wochenschr. 2007; 157(21-22): 540-544.
Doi: 10.1007/s10354-007-0481-z
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
2006
Originalarbeit (Zeitschrift)
** Hofmann, G; Bauernhofer, T; Krippl, P; Lang-Loidolt, D; Horn, S; Goessler, W; Schippinger, W; Ploner, F; Stoeger, H; Samonigg, H
Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation.
BMC Cancer. 2006; 6(2):1-1
Doi: 10.1186/1471-2407-6-1
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Schneider, J; Ruschhaupt, M; Buness, A; Asslaber, M; Regitnig, P; Zatloukal, K; Schippinger, W; Ploner, F; Poustka, A; Sültmann, H
Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.
Int J Cancer. 2006; 119(12):2974-2979
Doi: 10.1002/ijc.22234
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Keeling, IM; Ploner, F; Rigler, B
Familial cardiac angiosarcoma.
ANN THORAC SURG. 2006; 82(4): 1576-1576.
Doi: 10.1016/j.athoracsur.2006.03.006
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Leyvraz, S; Pampallona, S; Martinelli, G; Ploner, F; Aversa, S; Rosti, G; Brunsvig, P; Montes, A; Yilmaz, U; Perey, L
Randomized phase III study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer (SCLC): Results of the EBMT Random-ICE trial.
J CLIN ONCOL. 24(18):380S-380S.
[Poster]
Web of Science
2004
Originalarbeit (Zeitschrift)
** Regitnig, P; Ploner, F; Maderbacher, M; Lax, SF
Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors.
Mod Pathol. 2004; 17(5):597-602
Doi: 10.1038/modpathol.3800089
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schippinger, W; Regitnig, P; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Wehrschütz, M; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer.
ONCOL REP. 2004; 11(6): 1331-1336.
Doi: 10.3892/or.11.6.1331
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2003
Originalarbeit (Zeitschrift)
** Bauernhofer, T; Eibl, M; Ploner, F; Kuss, I; Pfeifer, J; Sill, H; Samonigg, H
Acute pseudo-obstruction of the small intestine following high-dose chemotherapy and stem cell support.
Onkologie. 2003; 26(4):344-346
Doi: 10.1159/000072093
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Ploner, F; Jakesz, R; Hausmaninger, H; Kolb, R; Stierer, M; Fridrik, M; Steindorfer, P; Gnant, M; Haider, K; Mlineritsch, B; Tschurtschenthaler, G; Steger, G; Seifert, M; Kubista, E; Samonigg, H; Austrian Breast And Colorectal Cancer Study Group
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Onkologie. 2003; 26(2):115-119
Doi: 10.1159/000069831
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
2002
Originalarbeit (Zeitschrift)
** Regitnig, P; Moser, R; Thalhammer, M; Luschin-Ebengreuth, G; Ploner, F; Papadi, H; Tsybrovskyy, O; Lax, SF
Microsatellite analysis of breast carcinoma and corresponding local recurrences.
J Pathol. 2002; 198(2):190-197
Doi: 10.1002/path.1193
Web of Science
PubMed
FullText
FullText_MUG
** Wehrschütz, M; Stöger, H; Ploner, F; Hofmann, G; Wolf, G; Höfler, G; Krippl, P; Samonigg, H
Seminoma metastases mimicking primary pancreatic cancer.
Onkologie. 2002; 25(4):371-373
Doi: 10.1159/000066057
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Ploner, F; Genser, B; Schippinger, W; Hofmann, G; Samonigg, H
The influence of prognostic factors seems to be constant throughout the course of metastatic breast cancer regardless of therapeutical intervention.
BREAST CANCER RES TREAT. 2002; 76: S48-S48.
Web of Science
** Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
1999
Übersichtsarbeit
** Bauernhofer, T; Stöger, H; Kasparek, AK; Ploner, F; Kuss, I; Pieber, TR; Kotz, R; Samonigg, H
Combined treatment of metastatic osteosarcoma of the spine.
Oncology. 1999; 57(4):265-268
Doi: 10.1159/000012058
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
** Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science
1994
Originalarbeit (Zeitschrift)
** Stöger, H; Bauernhofer, T; Kasparek, AK; Schmid, M; Moser, R; Ploner, F; Derstvenscheg, E; Kuss, I; Wilders-Truschnig, M; Steindorfer, P
Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1994; 34(1):75-78
Doi: 10.1007/BF00686116
Web of Science
PubMed
FullText
FullText_MUG
** Stöger, H; Bauernhofer, T; Moser, R; Derstvenscheg, E; Schmid, M; Ploner, F; Pakisch, B; Wilders-Truschnig, M; Haas, J; Steindorfer, P
Breast cancer in the man: a report of 30 patients].
Wien Klin Wochenschr. 1994; 106(18):575-580
Web of Science
PubMed
Google Scholar
** Stöger, H; Bauernhofer, T; Schmid, M; Ploner, F; Moser, R; Derstvenscheg, E; Steindorfer, P; Wilders-Truschnig, M; Kuss, I; Samonigg, H
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Cancer Chemother Pharmacol. 1994; 35(2):174-178
Doi: 10.1007/BF00686643
Web of Science
PubMed
FullText
FullText_MUG
** Stöger, H; Schmid, M; Bauernhofer, T; Moser, R; Ploner, F; Derstvenscheg, E; Kasparek, AK; Kuss, I; Wilders-Truschnig, M; Lackner, C
A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Oncology. 1994; 51(6):518-522
Doi: 10.1159/000227397
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar